BACKGROUND:Analysis of the chromosomal background upon which a mutation occurs can be used to reconstruct the origins of specific disease-causing mutations. The relatively common BRCA1 mutation, 1135insA, has been previously identified as a Norwegian founder mutation. We performed haplotype analysis of individuals from breast and ovarian cancer families from four different ethnic backgrounds who had been identified as carriers of the BRCA1: 1135insA mutation.METHODS:Four microsatellite markers (D17S855, D17S1322, D17S1323 and D17S1325) located within or near the BRCA1 gene were genotyped in mutation carriers from 6 families of French Canadian, Italian and Dutch descent. Haplotypes were inferred from the genotype data and compared between th...
The 999del5 mutation is the single, strong BRCA2 founder mutation in Iceland and the most common BRC...
BackgroundThe BRCA1 c.3331_3334delCAAG founder mutation has been reported in hereditary breast and o...
SummarySeveral BRCA2 mutations are found to occur in geographically diverse breast and ovarian cance...
BACKGROUND: Analysis of the chromosomal background upon which a mutation occurs can be used to recon...
We searched for a founder mutation in a population from one geographic region of Norway with prevale...
Familial breast-ovarian cancer has been demonstrated to be frequent but unevenly distributed in Norw...
Abstract Background Founder mutations in the two breast cancer genes, BRCA1 and BRCA2, have been des...
Abstract Background The 3398delAAAAG mutation in BRCA2 was recently found to recur in breast and/or ...
Recently, a 6-kb duplication of exon 13, which creates a frameshift in the coding sequence of the BR...
Since the identification of the BRCA1 and BRCA2 genes, several hundred different germline mutations ...
Cataloged from PDF version of article.Recently, a 6-kb duplication of exon 13, which creates a frame...
Recently, a 6-kb duplication of exon 13, which creates a frameshift in the coding sequence of the BR...
The most recurrent BRCA1/BRCA2 mutation in Sweden is the BRCA1 mutation 3171ins5. In the western par...
A total of 845 women from breast-ovarian cancer kindreds were enrolled in a clinical follow-up progr...
We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ...
The 999del5 mutation is the single, strong BRCA2 founder mutation in Iceland and the most common BRC...
BackgroundThe BRCA1 c.3331_3334delCAAG founder mutation has been reported in hereditary breast and o...
SummarySeveral BRCA2 mutations are found to occur in geographically diverse breast and ovarian cance...
BACKGROUND: Analysis of the chromosomal background upon which a mutation occurs can be used to recon...
We searched for a founder mutation in a population from one geographic region of Norway with prevale...
Familial breast-ovarian cancer has been demonstrated to be frequent but unevenly distributed in Norw...
Abstract Background Founder mutations in the two breast cancer genes, BRCA1 and BRCA2, have been des...
Abstract Background The 3398delAAAAG mutation in BRCA2 was recently found to recur in breast and/or ...
Recently, a 6-kb duplication of exon 13, which creates a frameshift in the coding sequence of the BR...
Since the identification of the BRCA1 and BRCA2 genes, several hundred different germline mutations ...
Cataloged from PDF version of article.Recently, a 6-kb duplication of exon 13, which creates a frame...
Recently, a 6-kb duplication of exon 13, which creates a frameshift in the coding sequence of the BR...
The most recurrent BRCA1/BRCA2 mutation in Sweden is the BRCA1 mutation 3171ins5. In the western par...
A total of 845 women from breast-ovarian cancer kindreds were enrolled in a clinical follow-up progr...
We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ...
The 999del5 mutation is the single, strong BRCA2 founder mutation in Iceland and the most common BRC...
BackgroundThe BRCA1 c.3331_3334delCAAG founder mutation has been reported in hereditary breast and o...
SummarySeveral BRCA2 mutations are found to occur in geographically diverse breast and ovarian cance...